Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment
October 23, 2023

Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment

Pangea announces its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.
Read More arrow arrow
Pangea Partners with FibroFighters to Advance Rare Liver Cancer Treatment
October 17, 2023

Pangea Partners with FibroFighters to Advance Rare Liver Cancer Treatment

Pangea will conduct ENLIGHT analyses for FibroFighters’ patients to suggest treatment avenues, compare recommended treatments to actual outcomes, and improve models for response prediction
Read More arrow arrow
Pangea Biomed’s Ranit Aharonov: “Cancer-hunting AI”
September 21, 2023

Pangea Biomed’s Ranit Aharonov: “Cancer-hunting AI”

The Sunday Times’ tech correspondent Danny Fortson brings on Ranit Aharonov to talk about this moment for artificial intelligence, studying the brain, Project Debater, neural networks, language’s AlphaGo moment, the big idea at Pangea, getting it into the hands of doctors and drug communities, the role of AI in this tool, the regulatory limits, and why she didn't debate the AI she created.
Read More arrow arrow
Precision Oncology Driven by Understanding Gene Interactions and Vulnerability of Tumors with Tuvik Beker and Ranit Aharonov
September 8, 2023

Precision Oncology Driven by Understanding Gene Interactions and Vulnerability of Tumors with Tuvik Beker and Ranit Aharonov

Karen Jagoda brings on Tuvik Beker and Ranit Aharonov to talk about precision oncology and the understanding of gene interactions and vulnerability of tumors.
Read More arrow arrow
Pangea Biomed: This Company Has Developed A Multi-Cancer And Multi-Therapy Response Predictor To Improve Patient Lives
July 18, 2023

Pangea Biomed: This Company Has Developed A Multi-Cancer And Multi-Therapy Response Predictor To Improve Patient Lives

Pangea CTO, Ranit Aharonov sat down with Amit Chowdhry from Pulse 2.0 to discuss her background in technology, all things Pangea and more!
Read More arrow arrow
Dr. Lillian Siu Joins Pangea Biomed’s Scientific Advisory Board
May 23, 2023

Dr. Lillian Siu Joins Pangea Biomed’s Scientific Advisory Board

Pangea announced that Dr. Lillian L. Siu, MD, FASCO, an internationally-renowned cancer researcher, has joined its scientific advisory board as the company continues to increase patient benefits by 5x using precision oncology and its multi-cancer response predictor.
Read More arrow arrow
Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study
March 23, 2023

Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study

Onconova Therapeutics on Thursday said it will collaborate with Pangea Biomed to identify biomarkers of response to Onconova's cancer drug candidate rigosertib.
Read More arrow arrow
Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib
March 23, 2023

Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib

Onconova Therapeutics and Pangea Biomed collaborate to leverage Pangea’s ENLIGHT platform in identifying biomarkers of response to Onconova's cancer drug candidate rigosertib.
Read More arrow arrow
Interview with Tuvik Beker – Downturns: How to Survive and Thrive
March 22, 2023

Interview with Tuvik Beker – Downturns: How to Survive and Thrive

In this edition of MASH (Marketing Advice for Startups in Healthcare), VSC sat down with Tuvik Beker, the CEO of Pangea Biomed, a startup building an algorithmic platform called ENLIGHT to democratize precision oncology.
Read More arrow arrow
Empowered Patient Podcast with Tuvik Beker
January 31, 2023

Empowered Patient Podcast with Tuvik Beker

Tuvik Beker, CEO of Pangea Biomed, sat down to chat with Karen Jagoda about how the company is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug.
Read More arrow arrow